This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This TPD52L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 43-70 amino acids from the N-terminal region of human TPD52L1.
TPD52L1
Reaktivität: Human
WB, ELISA, IHC, IP
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.42 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
d53 antikoerper, MGC84190 antikoerper, TPD52L1 antikoerper, zgc:110003 antikoerper, D53 antikoerper, hD53 antikoerper, tumor protein D52-like 1 antikoerper, tumor protein D52 like 1 L homeolog antikoerper, tumor protein D52 like 1 antikoerper, Tpd52l1 antikoerper, tpd52l1.L antikoerper, TPD52L1 antikoerper, tpd52l1 antikoerper
Hintergrund
This gene encodes a member of the tumor protein D52 (TPD52) family. The encoded protein contains a coiled-coil domain and may form homo- or hetero-dimer with TPD52 family members. The protein is reported to be involved in cell proliferation and calcium signaling. It also interacts with the mitogen-activated protein kinase kinase kinase 5 (MAP3K5/ASK1) and positively regulates MAP3K5-induced apoptosis. Multiple alternatively spliced transcript variants have been observed, but the full-length nature of some variants has not yet been determined.